LKFT · Lakefront Biotherapeutics NV ADR
United States · RS rating 57 · As of 2026-10-14
| Price | 29.40 USD |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 57 / 89 / 61 / 30 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 33 / 34 / 33 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -99.3% |
| Distance from 52-week high | +15.1% |
| Market cap (USD) | $1.8B |